Core Viewpoint - FedEx has restored its full-year revenue and profit guidance, indicating a clearer outlook for its business despite ongoing tariff pressures [1] Financial Performance - For fiscal year 2026, FedEx expects adjusted earnings per share to be between $17.20 and $19, slightly below the analyst average estimate of $18.25 [1] - The company anticipates revenue growth of up to 6% for the year, significantly exceeding the analyst forecast of 1.2% [1] - In the first fiscal quarter, FedEx reported adjusted net income of $910 million (or $3.83 per share), surpassing last year's $890 million (or $3.60 per share) and the analyst average estimate of $3.59 [3] - Quarterly revenue reached $22.24 billion, exceeding the market expectation of $21.66 billion [3] Business Operations - FedEx's strong performance is attributed to increased volume in high-margin priority delivery packages, a rise in domestic package volume, and cost-cutting measures [1] - The company has implemented a multi-billion dollar cost reduction plan, achieving a target of $1 billion in cost savings for the fiscal year [2] - Operating margin improved from 5.2% to 6%, supported by a 5% increase in domestic average daily deliveries [2] Market Context - FedEx's stock price rose over 5% in after-hours trading, although it has declined approximately 18% year-to-date, while the S&P 500 index has increased by about 13% [2] - The company is facing challenges from the termination of a long-standing trade policy that exempted low-value packages from tariffs, creating uncertainty in global freight operations [2] - Despite a 3% decline in international average daily export volume, FedEx's overall average daily package volume increased by 4%, and revenue per package rose by 2% [2] Strategic Initiatives - FedEx plans to continue its stock buyback program, having repurchased $500 million worth of shares in the first quarter [3] - The company aims to complete the spin-off of its freight business by June 2026 [3]

Investment Rating - The industry investment rating is "Positive" and is maintained [7] Core Insights - For FY2025Q2 (May 5, 2025 - August 3, 2025), the company achieved revenue of $2.53 billion, a year-on-year increase of 7%, which was slightly below market expectations (Bloomberg consensus expected $2.54 billion). The gross margin decreased by 1.1 percentage points to 58.5%, primarily due to increased discounts and tariffs leading to a 0.7 percentage point decline in product profit margins. The SG&A expense ratio increased by 0.9 percentage points, dragging down the net profit margin by 1.9 percentage points to 14.7% [2][5] Revenue Breakdown - Revenue by region showed that Greater China continued to experience high growth, while North America saw a slowdown. In FY2025Q2, revenue in the U.S./Canada/North America/Greater China grew by -0.5%/+1%/+1%/+24% year-on-year, with Greater China benefiting from continuous store openings and increased brand awareness. The U.S. market faced pressure mainly due to weak demand in the high-end apparel sector. By channel, offline/e-commerce revenue grew by +3%/+9% year-on-year, with offline revenue growth slowing and e-commerce maintaining good growth [10] Inventory Situation - Inventory continued to grow, with an expected slowdown in inventory growth in FY2026Q1. By the end of FY2025Q2, the company's inventory increased by 21% year-on-year to $1.72 billion. The increase in inventory was mainly due to excess seasonal stock, and the company aims to clear this stock before the end of the year. It is anticipated that inventory growth will be low double digits in FY2025Q3, with overall inventory growth maintained, and a slowdown in inventory growth expected in FY2026Q1 [10] Tariff Impact - Tariffs have negatively impacted gross margins and operating profit margins. The company plans to mitigate the impact of tariffs through cost control, pricing adjustments, and negotiations with suppliers [10] Performance Guidance - The company has lowered its full-year guidance, now expecting FY2025 revenue to be between $10.85 billion and $11.0 billion, a year-on-year increase of 2% to 4% (previous guidance was $11.15 billion to $11.3 billion, with Bloomberg consensus expecting $11.13 billion, a year-on-year increase of 5%). Revenue in North America is expected to decline by 1% to remain flat, while revenue in China is projected to grow by 20% to 25%. The full-year gross margin is expected to decrease by 3 percentage points, with EPS revised down to between $12.77 and $12.97. For FY2025Q3, revenue is expected to be between $2.47 billion and $2.5 billion, a year-on-year increase of 3% to 4%, with gross margin expected to decrease by 4.1 percentage points [10]

Core Viewpoint - Li Auto's Q3 performance guidance is significantly below market expectations, raising concerns about its future growth prospects [1][3]. Financial Performance - In Q2 2025, Li Auto reported revenue of 30.2 billion yuan, a year-on-year decrease of 4.5% but a quarter-on-quarter increase of 16.7% [3]. - The net profit for Q2 was 1.1 billion yuan, showing a slight year-on-year decline of 0.4% but a substantial quarter-on-quarter increase of 69.6% [3]. - For the first half of 2025, total revenue was 56.172 billion yuan, down 2% year-on-year, while net profit increased by 3% to 1.744 billion yuan [3]. Vehicle Sales - Li Auto delivered 204,000 vehicles in the first half of 2025, marking a year-on-year growth of 7.9% [3]. - The vehicle sales revenue for the first half was 53.564 billion yuan, a year-on-year decrease of 1.8% [3]. Cash Reserves - As of the end of Q2 2025, Li Auto's cash reserves stood at 106.9 billion yuan, indicating a strong liquidity position [3]. Q3 Guidance - For Q3 2025, Li Auto expects vehicle sales to be between 90,000 and 95,000 units, representing a year-on-year decline of 41.1% to 37.8% [3]. - The projected revenue for Q3 is estimated to be between 24.8 billion and 26.2 billion yuan, reflecting a year-on-year decrease of 42.1% to 38.8% [3]. Market Context - In July 2025, Li Auto's sales were 30,700 units, down 39.74% year-on-year and 15.29% month-on-month [4]. - The CEO of Li Auto emphasized the need for faster technology and product updates to remain competitive in the market [4].

Core Viewpoint - Automatic Data Processing (ADP) reported strong fourth-quarter fiscal 2025 results, with earnings and revenues exceeding estimates, but has seen a recent decline in share performance compared to the S&P 500 [1][2]. Financial Performance - ADP's earnings per share (EPS) for Q4 fiscal 2025 was $2.26, beating the consensus estimate by 1.8% and increasing 8.1% year-over-year [2]. - Total revenues reached $5.1 billion, surpassing estimates by 1.5% and growing 5.7% year-over-year [2]. Segmental Results - Employer Services generated revenues of $3.5 billion, an 8% increase on a reported basis but missed the estimate of $3.8 billion [3]. - PEO Services revenues rose 9% year-over-year to $1.2 billion, falling short of the $1.7 billion estimate [3]. - Average worksite employees paid by PEO Services increased by 3% to 761,000 [3]. Interest and Client Funds - Interest on funds held for clients grew 11% year-over-year to $308 million, missing the estimate of $342.4 million [4]. - The average client funds balance increased by 6% to $38.1 billion, with the average interest yield expanding by 20 basis points to 3.2% [4]. Margins - Adjusted EBIT rose 9% year-over-year to $5.3 billion, with the adjusted EBIT margin increasing by 50 basis points to 26% [5]. - The margin for Employer Services increased by 50 basis points, while PEO Services saw a decrease of 20 basis points [5]. Balance Sheet and Cash Flow - At the end of Q4 fiscal 2025, ADP had cash and cash equivalents of $3.3 billion, up from $2.7 billion in the previous quarter [6]. - Long-term debt increased to $4 billion from $3 billion in the preceding quarter [6]. - The company generated $1.4 billion in cash from operating activities during the quarter [6]. Fiscal 2025 Outlook - ADP lowered its revenue growth guidance for fiscal 2025 to 5-6% from the previous 6-7% [7]. - Adjusted EPS growth guidance was updated to 8-10% from 8-9% [7]. - The adjusted effective tax rate is estimated at 23%, and the guidance for adjusted EBIT margin was raised to 50-70 basis points [7]. Estimate Trends - There has been a downward trend in estimates for ADP, indicating a shift in expectations [10][12]. - The stock currently holds a Zacks Rank 3 (Hold), suggesting an expectation of in-line returns in the coming months [12].

Core Viewpoint - Marvell Technology (MRVL.US) reported a record revenue of $2.01 billion for Q2, a 58% year-over-year increase, but this only met Wall Street analysts' expectations, leading to an approximate 11.3% drop in after-hours trading to $68.52 [1] Financial Performance - Q2 revenue reached a record $2.01 billion, reflecting a 58% year-over-year growth [1] - Adjusted earnings per share were $0.67, aligning with analysts' expectations [1] Guidance and Market Reaction - The company provided a Q3 revenue guidance midpoint of approximately $2.06 billion, slightly below analysts' expectations of $2.11 billion [1] - The lack of an "upside" signal in performance guidance contributed to the negative market reaction [1] Business Outlook - CEO Matt Murphy indicated that growth in the custom chip business is expected to be "non-linear," suggesting a flat performance in Q3 but a significant improvement in Q4 [1]

Core Insights - Rogers Communications reported Q2 2025 adjusted earnings of 82 cents per share, beating estimates by 2.5% but down 3.5% year over year [3] - Total revenues reached C$5.22 billion, a 2.4% increase year over year, driven by growth in Wireless, Cable, and Media segments [4] Financial Performance - Adjusted EBITDA rose 1.6% year over year to C$2.36 billion, with a margin contraction of 40 basis points to 45.3% [11] - Free cash flow increased by 38.9% year over year to C$925 million, supported by higher adjusted EBITDA and lower capital intensity [14] Segment Analysis - Wireless revenues, accounting for 48.7% of total revenues, increased 3% year over year to C$2.54 billion, with service revenues rising 0.6% [5] - Cable revenues grew 0.2% year over year to C$1.97 billion, while equipment revenues saw a significant decline of 56.3% [7] - Media revenues increased 9.8% year over year to C$808 million, with operating expenses rising 9.1% [10] Subscriber Metrics - As of June 30, 2025, postpaid wireless subscribers totaled 10.91 million, with net additions of 312K year over year [6] - Retail Internet subscribers reached nearly 4.446 million, reflecting a net increase of 232K year over year [7] Balance Sheet and Liquidity - Available liquidity as of June 30, 2025, was C$11.8 billion, up from C$7.5 billion as of March 31, 2025 [12] - The debt leverage ratio improved to 3.6 times, nearing pre-acquisition levels, indicating accelerated deleveraging progress [13] Guidance and Outlook - For 2025, the company expects total service revenue growth of 3% to 5% and adjusted EBITDA growth of 0% to 3% [15] - Estimates for the stock have been trending upward, with a Zacks Rank of 3 (Hold), indicating an expectation of in-line returns in the coming months [19]

Group 1 - Bayer has raised its 2025 performance outlook due to better-than-expected pharmaceutical business performance in the first half of the year, now expecting sales between €46 billion and €48 billion, and EBITDA between €9.7 billion and €10.2 billion [1] - The previous sales forecast was between €45 billion and €47 billion, with EBITDA expected to be between €9.5 billion and €10 billion [1] - The updated guidance considers the anticipated financial impact of current U.S. government tariff policies, with ongoing assessments of related dynamics [1] Group 2 - Bayer warned of "significant" currency fluctuations, expecting a negative impact on sales and profits, but a beneficial effect on net financial debt [1] - Currency fluctuations are projected to reduce sales by approximately €2 billion and EBITDA by about €500 million, while potentially benefiting net financial debt by around €1.2 billion [1] - In Q2, Bayer reported a net loss of €199 million, with EBITDA and operating profit plummeting by 83% and 97% to €28.5 million and €1.3 million, respectively, primarily due to a one-time charge of €981 million [2]

Core Insights - Amdocs Limited (DOX) reported better-than-expected third-quarter fiscal 2025 results with non-GAAP earnings of $1.72 per share, exceeding management's guidance and the Zacks Consensus Estimate [1][10] - The company's revenues for Q3 were $1.14 billion, surpassing the consensus mark but down 8.4% year over year due to the phase-out of certain business activities [2][10] Financial Performance - Non-GAAP operating income increased 5.3% year over year to $244.7 million, with an operating margin expansion of 280 basis points to 21.4% [5] - Managed services revenues rose 4.1% year over year to $771.5 million, while the company ended the quarter with a backlog of $4.15 billion [5] - Amdocs generated operating cash flow of $241.2 million and free cash flow of $211.8 million during the third quarter [7] Revenue Breakdown - North America revenues were $745.4 million, representing 65.1% of total revenues, down 10.1% year over year [3] - Revenues from the Rest of the World (RoW) declined 14.5% year over year to $209.6 million, while Europe revenues increased 7.7% year over year to $189.4 million [3][4] Guidance and Outlook - For Q4, Amdocs expects revenues between $1.125 billion and $1.165 billion, with non-GAAP earnings per share projected between $1.79 and $1.85 [8][9] - The updated guidance for fiscal 2025 indicates a revenue decline rate of 9.0-10.0%, with a mid-point suggesting a decline of 9.5% [11] - Non-GAAP earnings per share growth is now expected in the range of 8.0-9.0%, up from previous forecasts [12]

Investment Rating - The investment rating for the industry is "Positive" and maintained [6] Core Insights - In FY2025Q2 (April 1, 2025 - June 30, 2025), Adidas reported revenue of €5.95 billion, which was below the expected €6.21 billion, showing a year-on-year growth of 8% at constant exchange rates, and a 12% increase when excluding the impact of Yeezy. The net profit attributable to shareholders was €370 million, exceeding the expected €340 million, with a year-on-year increase of 95%. The gross margin improved by 0.9 percentage points to 51.7%, primarily due to better product discounting and reduced shipping costs [2][4] Summary by Sections Revenue Performance - Adidas achieved revenue of €5.95 billion in FY2025Q2, which was lower than the expected €6.21 billion, with a year-on-year growth of 8% at constant exchange rates and 12% when excluding Yeezy [2][4] - The company's net profit was €370 million, surpassing the expected €340 million, reflecting a year-on-year increase of 95% [2][4] Gross Margin and Costs - The gross margin increased by 0.9 percentage points to 51.7%, attributed to improved product discounting and lower shipping costs [2][4] Market Performance - In FY2025Q2, Adidas' revenue growth in Europe, North America, and Greater China was 7%, 15%, and 11% respectively, with all markets except Europe achieving double-digit growth [10] - Direct-to-Consumer (DTC) and wholesale channels grew by 3% and 11% year-on-year respectively, indicating overall positive channel performance [10] Inventory and Cost Impacts - The inventory level was €5.26 billion, up 16% year-on-year, maintaining a healthy status in line with revenue growth [10] - Tariff impacts resulted in a negative effect of several million euros, with an expected increase in sales costs of €200 million in H2 [10] Performance Guidance - The company maintained its full-year guidance, expecting high single-digit revenue growth at constant exchange rates for FY2025, with an operating profit forecast of €1.7 to €1.8 billion, below market expectations of €2 billion [10]

Group 1 - Novo Nordisk has lowered its 2025 fiscal year performance guidance, indicating a potential conservative management approach or a substantial deterioration in business prospects [1][4] - Deutsche Bank's report suggests that the new management's growth targets are very conservative, with the current market pricing Novo Nordisk as a mature pharmaceutical stock [1][4] - The revised guidance for 2025 sales growth is now set at 8-14% and EBIT growth at 10-16%, which is close to Deutsche Bank's previous expectations [4] Group 2 - The competition from compounded drugs continues to affect Novo Nordisk, with approximately 1 million patients in the U.S. still using compounded medications [2] - Despite an increase in 503A supply to offset the decline in 503B, the overall competitive landscape has not improved [2] - Analysts believe that Novo Nordisk should expand its market for semaglutide-based drugs in the second half of the year, but failure to do so may indicate issues with the total addressable market (TAM) theory [2] Group 3 - The new CEO of Novo Nordisk prioritizes innovation investment and business execution, with cash prescription business share rising from 4% to 12% since the beginning of the year [3] - The company confirmed that out of 100 million obese individuals, 55 million have employer-sponsored insurance for Wegovy, with compounded drugs accounting for 30% of the market [3] - Wegovy's prescription volume is approximately 275,000, with new prescription share exceeding 40% [3]